AngioWaveNet vs Imbio PHA (4.0.0)
AI Verdict
Choose AngioWaveNet if…
Choose AngioWaveNet if your primary need is to enhance the clarity and visibility of blood vessels and anatomical features during live fluoroscopic angiogram procedures in the cardiac catheterization lab. This tool is ideal for improving real-time visualization for interventional cardiologists, integrating seamlessly into existing cath lab workflows and being compatible with various angiography systems.
View AngioWaveNet →Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA (4.0.0) if you require automated, quantitative analysis of cardiac structures from CT pulmonary angiogram (CTPA) scans to assist in the diagnosis and risk stratification of pulmonary embolism and hypertension. This software excels at rapidly measuring ventricular and arterial diameters and ratios, providing objective data and reports to support radiologists and cardiologists in their post-acquisition assessment.
View Imbio PHA (4.0.0) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AngioWaveNet | Imbio PHA (4.0.0) |
|---|---|---|
| Pricing | Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. | Unknown |
| Deployment | Cloud-based or on-premise/servers | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio PHA (4.0.0)Tool B emphasizes rapid, fully-automated assessment and direct generation of annotated DICOMs and PDF reports, suggesting a highly streamlined user experience. While Tool A integrates well with existing workflows and is vendor-agnostic, Tool B's automation for quantitative analysis potentially reduces manual effort and speeds up diagnostic workflows.
Clinical Value
Imbio PHA (4.0.0)Tool B provides direct, quantitative measurements and ratios from CTPA scans for specific conditions like pulmonary embolism and hypertension, aiding in diagnosis and risk stratification. While Tool A enhances visualization for existing procedures, Tool B delivers more immediately actionable diagnostic and prognostic data. Both are FDA-cleared, indicating validated clinical utility.
Pricing & Value
AngioWaveNetTool A offers transparent pricing models including annual licensing and subscription options, tailored to cath lab volume and hospital needs, with custom packages available. This contrasts with Tool B's 'contact for pricing' approach, which provides no initial transparency for potential customers to assess value.
Enterprise Readiness
Imbio PHA (4.0.0)Tool B explicitly states third-party HIPAA certification by Compliancy Group and the availability of a Business Associate Agreement (BAA), alongside flexible deployment options including partner integration. While Tool A is HIPAA compliant and offers cloud/on-premise deployment, Tool B's detailed compliance claims indicate a more robust enterprise offering.
Innovation
Imbio PHA (4.0.0)Tool B's AI-powered automated measurement of cardiac structures and calculation of critical ratios from CTPA scans for diagnosis and risk stratification represents a significant innovation in automating complex quantitative clinical assessment. While Tool A's AI-powered spatiotemporal enhancement for improved visualization is innovative, Tool B's extraction of new, actionable quantitative data for specific clinical questions stands out.
Support & Docs
TieNeither the provided structured facts nor a general web search yielded specific information regarding dedicated support portals, service level agreements, or comprehensive documentation for either product. Therefore, it is not possible to distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AngioWaveNet | Imbio PHA (4.0.0) |
|---|---|---|
| Name | AngioWaveNet | Imbio PHA (4.0.0) |
| Company | Angiowave Imaging | Imbio |
| Primary Function | Enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. | Automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in diagnosis and risk stratification of pulmonary embolism and hypertension. |
| Key AI Capability | AI-powered Spatiotemporal Enhancement Processing (STEPu2122) for improved vessel visualization. | Automated measurement of right/left ventricle diameters, main pulmonary artery/aorta diameters, and calculation of RV/LV and PA/Ao ratios using AI algorithms. |
| Integration | Integrates with existing Cath lab workflows; functions as a DICOM endpoint. | Integrates with native DICOM tools and workflows. |
| Output/Result Type | Enhanced visibility of blood vessels, vascular structures, and anatomical features in angiographic images. | Annotated DICOM images and summary reports in PDF format. |
Videos
Demos, reviews, and walkthroughs featuring AngioWaveNet and Imbio PHA (4.0.0).